A. Saunders

A. Roses, A. Saunders, D. Schmechel, 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype

Robert C. Green, Sterling C. Johnson, Barbara B. Bendlin, 2011, Alzheimer's & Dementia.

Reassessment of Pioglitazone for Alzheimer’s Disease

A. Saunders, D. Burns, W. Gottschalk, 2021, Frontiers in Neuroscience.

Characterization of murine carcinoembryonic antigen gene family members

W. Zimmermann, A. Saunders, F. Rudert, 2004, Mammalian Genome.

A single-nucleotide polymorphism tagging set for human drug metabolism and transport

Nicole Soranzo, Nicholas W Wood, David B Goldstein, 2005, Nature Genetics.

Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation

J. Gilbert, M. Pericak-Vance, A. Saunders, 2000, Acta Neuropathologica.

Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases

M. Pericak-Vance, A. Roses, K. Schmader, 1993, The Lancet.

Analysis of association at single nucleotide polymorphisms in the APOE region.

J. Gilbert, M. Pericak-Vance, A. Roses, 2000, Genomics.

No association between the HLA-A2 allele and Alzheimer disease

J. Haines, M. Pericak-Vance, A. Roses, 1999, Neurogenetics.

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

Michael Gold, Suzanne Craft, Ann M. Saunders, 2010, Dementia and Geriatric Cognitive Disorders.

Gene identification in Alzheimer's disease.

A. Saunders, A M Saunders, 2001, Pharmacogenomics.

Clusters of adjacent and similarly expressed genes across normal human tissues complicate comparative transcriptomic discovery.

D. Searls, A. Roses, A. Saunders, 2005, Omics : a journal of integrative biology.

Structural Variants May Be a Source of Missing Heritability in sALS

F. Mastaglia, A. Saunders, D. Burns, 2020, Frontiers in Neuroscience.

Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease

A. Saunders, A. Yoder, P. Larsen, 2017, Chromosome Research.

A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative.

J. Haines, M. Pericak-Vance, N. Risch, 2001, Multiple sclerosis.

Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease

Michael Lutz, Scott Sundseth, A. Roses, 2016, Alzheimer's & Dementia.

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

J. Haines, M. Pericak-Vance, E. Martin, 2002, American journal of human genetics.

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

J. Haines, M. Pericak-Vance, A. Roses, 1997, JAMA.

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

A D Roses, M A Pericak-Vance, M. Pericak-Vance, 1993, Proceedings of the National Academy of Sciences of the United States of America.

APOE is a major susceptibility gene for Alzheimer's disease.

A D Roses, A. Roses, A. Saunders, 1994, Current opinion in biotechnology.

Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort

A. Roses, I. James, F. Mastaglia, 2020, Neurology: Genetics.

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)

A D Roses, A. Roses, R. Mahley, 2007, The Pharmacogenomics Journal.

Familial Neuropathology and sporadic Alzheimer ’ s disease : cannot exclude a final common pathway

D. Pollen, B. Hyman, P. S. St George-Hyslop, 2007 .

Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity.

J. Haines, M. Pericak-Vance, A. Roses, 2000, American journal of human genetics.

Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K)

J. Haines, M. Pericak-Vance, A. Roses, 1999, Neuroscience Letters.

No association of α 1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients

J. Haines, M. Pericak-Vance, A. Roses, 1998, Neuroscience Letters.

Amyloid-β-protein isoforms in brain of subjects with PS1-linked, βAPP-linked and sporadic Alzheimer disease

D. Pollen, A. Roses, R. Sherrington, 1998 .

No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease

J. Haines, M. Pericak-Vance, A. Roses, 1998, Neurogenetics.

Proteolytic processing of presenilin‐1 (PS‐1) is not associated with Alzheimer's disease with or without PS‐1 mutations

A. Roses, P. S. St George-Hyslop, C. van Broeckhoven, 1997, FEBS letters.

D2 dopamine receptor A1 allele in Alzheimer disease and aging.

J. Haines, M. Pericak-Vance, A. Roses, 1997, Archives of neurology.

No Association between α1‐Antichymotrypsin and Familial Alzheimer's Diseases a

J. Haines, M. Pericak-Vance, A. Roses, 1996 .

Alzheimer's disease and apolipoprotein e‐4 allele in an amish population

J. Haines, M. Pericak-Vance, C. C. Johnson, 1996, Annals of neurology.

D 2 Dopamine Receptor A 1 Allele in Alzheimer Disease and Aging

J. Haines, M. Pericak-Vance, A. Roses, 2022 .

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

A D Roses, A. Roses, A. Saunders, 2006, The Pharmacogenomics Journal.

Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis

J. Haines, M. Pericak-Vance, Robert H. Brown, 2004, Neurogenetics.

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.

Eden R Martin, Rajesh Pahwa, Clemens R Scherzer, 2003, Human molecular genetics.

Apolipoprotein E and Intellectual Achievement

G. Alexander, J. Hardy, E. Reiman, 2002, Journal of the American Geriatrics Society.

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Kewei Chen, Daniel Bandy, Eric M Reiman, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Clinical Trials of AD Delay of Onset: Enrichment by a Prognostic Genetic Biomarker

A. Roses, A. Saunders, O. Chiba-Falek, 2013 .

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Jennifer G. Robinson, Alex A. Knopman, D. Rujescu, 2021, The Lancet Neurology.

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

M. Pericak-Vance, A. Roses, A. Saunders, 1995, Neurobiology of Aging.

A proximal mouse chromosome 9 linkage map that further defines linkage groups homologous with segments of human chromosomes 11, 15, and 19.

M. Seldin, A. Saunders, T. Howard, 1991, Genomics.

Mouse chromosome 7

A. Saunders, J. Peters, M. Sutcliffe, 2004, Mammalian Genome.

Reply to 'Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10'

D. Goldstein, A. Roses, M. Weale, 2005, Nature Genetics.

Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition

A. M. Saunders, K. Welsh-Bohmer, A. Saunders, 1997, Neurology.

Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition.

K. Welsh-Bohmer, A. Saunders, E. Bigler, 1997, Neurology.

ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation

A. Roses, A. Saunders, M. Goedert, 1995, Neuroscience Letters.

Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype

Margaret A. Pericak-Vance, Seol-Heui Han, John R. Gilbert, 1994, Experimental Neurology.

ApoE genotype-specific inhibition of apoptosiss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains two supplemental figures. Published, JLR Papers in Press, May 16, 2003. DOI 10.1194/jlr.M300097-JLR200

A. Saunders, W. Strittmatter, Jennifer B. Robinette, 2003, Journal of Lipid Research.

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

D. Mash, K. Welsh-Bohmer, A. Saunders, 1998, Journal of neuropathology and experimental neurology.

Apolipoprotein E and Alzheimer’s Disease: State of the Field After Two Years

M. Pericak-Vance, A. Roses, A. Saunders, 1996 .

New applications of disease genetics and pharmacogenetics to drug development.

A. Roses, A. Hariri, S. Brannan, 2014, Current opinion in pharmacology.

Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.

A. Roses, J. Mortimer, A. Saunders, 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

Genetic Predictors of Perioperative Neurologic and Neuropsychological Injury and Recovery

A. Saunders, M. Newman, H. Grocott, 1999 .

Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease

J. Haines, M. Pericak-Vance, A. Roses, 1995, Neurology.

Apolipoprotein E genotype and Lewy body disease

A. Roses, J. Hardy, D. Dickson, 1995, Neurology.

Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses

A. Saunders, 2000, Journal of neuropathology and experimental neurology.

The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.

A D Roses, A. Roses, T. Mansfield, 2000, Biochimica et biophysica acta.

Complex Genetic Disease: Can Genetic Strategies in Alzheimer's Disease and New Genetic Mechanisms Be Applied to Epilepsy?

M. Pericak-Vance, A. Roses, A. Saunders, 1994, Epilepsia.

Apolipoprotein E alleles in childhood-onset schizophrenia.

J. Rapoport, M. Schapiro, S. Hamburger, 1999, American journal of medical genetics.

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia

A. Roses, A. Saunders, N. Spurr, 2004, The Pharmacogenomics Journal.

Preliminary Report on the Association of Apolipoprotein E Polymorphisms, with Postoperative Peak Serum Creatinine Concentrations in Cardiac Surgical Patients

W. White, A. Saunders, W. Strittmatter, 2000, Anesthesiology.

Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia aging study.

R. Havlik, J. Kardaun, A. Saunders, 2000, Clinical chemistry.

Perspective on a pathogenesis and treatment of Alzheimer’s disease

A. Roses, A. Saunders, 2006, Alzheimer's & Dementia.

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

M. Pericak-Vance, A. Roses, A. Saunders, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.

J. Gilbert, J. Haines, M. Pericak-Vance, 2003, American journal of human genetics.

A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for alzheimer's disease

David C. Steffens, Kathleen A. Welsh-Bohmer, Michael J. Helms, 1997, Biological Psychiatry.

Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease

M. Pericak-Vance, A. Roses, A. Saunders, 1994, Neuroscience Letters.

Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline

D. Bennett, J. Farfel, A. Saunders, 2017, Alzheimer's & Dementia.

TOMM40′523 variant and cognitive decline in older persons with APOE ε3/3 genotype

A. Roses, C. Gaiteri, D. Bennett, 2017, Neurology.

Longitudinal modeling of cognitive aging and the TOMM40 effect

A. Roses, E. Reiman, R. Caselli, 2012, Alzheimer's & Dementia.

A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging

A. Roses, K. Welsh-Bohmer, A. Saunders, 2012, Alzheimer's & Dementia.

Risk of Alzheimer Disease with the ±4 Allele for Apolipoprotein E in a Population‐Based Study of Men Aged 62–73 Years

A. Saunders, G. Jarvik, J. Breitner, 1998, Alzheimer disease and associated disorders.

Uptake and Internalization of Exogenous Apolipoprotein E3 by Cultured Human Central Nervous System Neurons

A. Roses, A. Saunders, P. Armati, 1998, Neurobiology of Disease.

No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians

J. Haines, M. Pericak-Vance, G. Small, 1996, Neuroscience Letters.

No Genetic Effect of α1-Antichymotrypsin in Alzheimer Disease

J. Haines, M. Pericak-Vance, A. Roses, 1996 .

The Relationship of APOE Genotype to Cognitive Functioning in Older African‐American and Caucasian Community Residents

Tamara B. Harris, D. Blazer, G. Fillenbaum, 2001, Journal of the American Geriatrics Society.

Association between bleomycin hydrolase and Alzheimer's disease in caucasians

J. Haines, M. Pericak-Vance, A. Roses, 1998, Annals of neurology.

Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's disease

M. Pericak-Vance, A. Roses, S. Tsuji, 1996, Annals of neurology.

A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.

K. Welsh-Bohmer, D. Steffens, A. Saunders, 1997, Biological psychiatry.

APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans

A. Roses, C. Gaiteri, D. Bennett, 2017, PloS one.

Further evidence linking late-onset Alzheimer disease with chromosome 12.

J. Haines, M. Pericak-Vance, A. Roses, 1999, JAMA.

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial

L. Schneider, C. Lyketsos, A. Monsch, 2019, Alzheimer's & dementia.

A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease

A. Roses, K. Welsh-Bohmer, A. Saunders, 2016, Alzheimer's & dementia.

Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft

W. White, A. Saunders, M. Newman, 2001, Anesthesia and analgesia.

Familial and sporadic Alzheimer's disease

D. Pollen, B. Hyman, P. S. St George-Hyslop, 1996, Neurology.

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

A. Roses, R. Mahley, A. Saunders, 2008, Proceedings of the National Academy of Sciences.

Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936☆

Joanna M. Wardlaw, Mark E. Bastin, Ian J. Deary, 2014, Neurobiology of Aging.

Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice

J. Gilbert, A. Roses, P. Xu, 1996, Neurobiology of Disease.

An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease

J. Haines, M. Pericak-Vance, A. Roses, 1999, Nature Genetics.

Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender.

J L Haines, M A Pericak-Vance, S Schmidt, 2000, Molecular vision.

A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy

J. Haines, M. Pericak-Vance, D. Weeks, 2002, Ophthalmic genetics.

Interactions of Apolipoprotein E with Microtubule-Associated Proteins

A. Saunders, W. Strittmatter, A. Roses, 1996 .

Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation

T. Montine, A. Saunders, W. Strittmatter, 1996, Journal of neuropathology and experimental neurology.

Morphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular Metabolism a

J. Gilbert, M. Pericak-Vance, A. Roses, 1996, Annals of the New York Academy of Sciences.

Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance.

M. Folstein, D. Steffens, W. McDonald, 1995, Archives of neurology.

Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis

I. James, F. Mastaglia, N. Siddique, 2020, Neurology: Genetics.

Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis

J. Haines, M. Pericak-Vance, Robert H. Brown, 1998, Neurogenetics.

Apolipoprotein E E4 allele and risk of dementia.

M. Pericak-Vance, A. Roses, A. Saunders, 1995, JAMA.

Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype

I. James, F. Mastaglia, A. Saunders, 2021, Frontiers in Aging Neuroscience.

TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial

A. Roses, A. Saunders, I. Grossman, 2013, Alzheimer's & Dementia.

Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates

Richard J. Caselli, Nick C. Fox, Gene E. Alexander, 2007 .

Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaging a

J. Mazziotta, J. Haines, M. Pericak-Vance, 1996, Annals of the New York Academy of Sciences.

Structural variants can be more informative for disease diagnostics, prognostics and translation than current SNP mapping and exon sequencing

Michael W. Lutz, A. D. Roses, Daniel K. Burns, 2016, Expert opinion on drug metabolism & toxicology.

Dementia with Lewy bodies and Alzheimer's disease

A. Saunders, C. Hulette, L. McIntyre, 2001, Acta Neuropathologica.

APOE/TOMM 40 genetic loci, white matter hyperintensities, and cerebral microbleeds

I. Deary, A. Roses, M. Bastin, 2015, International journal of stroke : official journal of the International Stroke Society.

Safety and tolerability of rosiglitazone XR in a randomised, placebo-controlled study in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease

A. Saunders, M. Irizarry, G. Landreth, 2009, Alzheimer's & Dementia.

Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease

A. Saunders, G. Landreth, S. Craft, 2009, Alzheimer's & Dementia.

Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls

M. Pericak-Vance, A. Roses, A. Saunders, 1994, Experimental Neurology.

Apolipoprotein E alleles in sporadic inclusion‐body myositis and hereditary inclusion‐body myopathy

A. Roses, A. Saunders, K. Weisgraber, 1996, Annals of neurology.

Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study

A. Roses, A. Saunders, W. Strittmatter, 1994, Journal of neuropathology and experimental neurology.

Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implications

M. Pericak-Vance, A. Roses, A. Saunders, 1994 .

Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.

J. Haines, M. Pericak-Vance, A. Roses, 1999, American Journal of Psychiatry.

Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsy.

A. Saunders, I. Litvan, 1998, Archives of neurology.

Locus Heterogeneity of Alzheimer’s Disease

J. Gilbert, M. Pericak-Vance, A. Roses, 1992 .

TOMMORROW: RESULTS FROM A PHASE 3 TRIAL TO DELAY THE ONSET OF MCI DUE TO AD AND QUALIFY A GENETIC BIOMARKER ALGORITHM

K. Welsh-Bohmer, A. Saunders, J. Burke, 2019, Alzheimer's & Dementia.

There Is a Pathologic Relationship Between ApoE-ε4 and Alzheimer's Disease-Reply

M. Pericak-Vance, A. Roses, E. Corder, 1995 .

Clinical overdiagnosis of vascular dementia versus necropsy confirmed series.

A. Roses, A. Saunders, 1997, Journal of neurology, neurosurgery, and psychiatry.

Apolipoprotein E ε4 and Risk of Mortality in African American and White Older Community Residents

D. Blazer, G. Fillenbaum, A. Saunders, 2002 .

Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents.

D. Blazer, G. Fillenbaum, A. Saunders, 2002, The Gerontologist.

Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF).

A. Saunders, A D Roses, M Pröschel, 1992, Human molecular genetics.

The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease.

J. Haines, M. Pericak-Vance, A. Roses, 1995, JAMA.

Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease

J. Gilbert, J. Haines, M. Pericak-Vance, 2004, Neurogenetics.

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone.

A. Roses, P. Cutler, A. Saunders, 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease.

J. Haines, M. Pericak-Vance, A. Roses, 1999, Nature genetics.

Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly.

A. Roses, J. Sidtis, D. Greenblatt, 2011, Journal of clinical psychopharmacology.

The Search for Additional Alzheimer’s Disease Genes

J. Haines, M. Pericak-Vance, A. Roses, 1996 .

Clinical features of seizures associated with parahippocampal/inferior temporal lesions compared to those with hippocampal sclerosis

G. Jackson, S. Berkovic, A. Saunders, 2010, Epilepsia.

Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

A. D. Roses, M. Pericak-Vance, A. Roses, 2006 .

Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease

A. Saunders, G. Landreth, S. Craft, 2009, Alzheimer's & Dementia.

Patterns of brain activation in people at risk for Alzheimer's disease.

Mark S. Cohen, J. Mazziotta, M. Pericak-Vance, 2000, The New England journal of medicine.

Protein: protein interactions in Alzheimer's disease and the CAG triplet repeat diseases.

A. Roses, J. Vance, A. Saunders, 1996, Cold Spring Harbor symposia on quantitative biology.

Identification of Novel Genes in Late-Onset Alzheimer's Disease

P. M. Conneally, J. M. Vance, J. L. Haines, 2000, Experimental Gerontology.

Using Genetics to Enable Studies on the Prevention of Alzheimer's Disease

A. Roses, K. Welsh-Bohmer, S. Brannan, 2013, Clinical pharmacology and therapeutics.

Characterization of APOE and TOMM40 allele frequencies in the Japanese population

A. Roses, A. Saunders, Yuka Maruyama, 2017, Alzheimer's & dementia.

Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.

A. Roses, A. Saunders, C. Hulette, 1998, Journal of neuropathology and experimental neurology.

Head injury, amyloid β and Alzheimer's disease

A. Roses, A. Saunders, 1995, Nature Medicine.

The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease

J. Haines, M. Pericak-Vance, A. Roses, 2003, Neuroscience Letters.

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

J. Haines, M. Pericak-Vance, A. Roses, 1996, Genomics.

O3-02-07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

A. Roses, Caifu Chen, K. Kelnar, 2008, Alzheimer's & Dementia.

Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease.

D. Pollen, A. Roses, R. Sherrington, 1998, Brain Research. Molecular Brain Research.

Genetic variation at a single locus and age of onset for Alzheimer's disease

A. Roses, A. Saunders, M. Lutz, 2010, Alzheimer's & Dementia.

The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease.

A. Saunders, S. Luo, W. Gottschalk, 2017, Biochimica et biophysica acta. Molecular basis of disease.